GE HealthCare Technologies Inc.(GEHC)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

GE HealthCare Technologies Inc. (GEHC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GEHC at 55.7/100 on a 32-signal composite quality model, placing it at rank #1,225 of 2,961 stocks — the top half of the AI-ranked universe. GEHC scores in the top quartile across revenue scale (92.8). Areas of concern include free cash flow (27.2) and revenue growth (37.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), GE HealthCare Technologies Inc. reports quarterly revenue of $5.1B, net income of $389.0M, an operating margin of 10.0%. Top institutional holders of GEHC by reported 13-F value include DODGE & COX, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. GEHC trades on the Nasdaq exchange and files with the SEC under CIK 1932393. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GEHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GE HealthCare Technologies Inc. directly from SEC EDGAR.

AI Quality Score

55.7/100

AI Rank

#1,225

Revenue

$5.1B

Net Income

$389.0M

Free Cash Flow

$112.0M

Operating Margin

10.0%

GEHC key financials by period

GE HealthCare Technologies Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$20.6B$2.1B13.4%
FY 202410-K$19.7B$2.0B13.3%
FY 202310-K$19.6B$1.6B12.4%
FY 202210-K$18.3B$1.9B13.8%
FY 202110-K$17.6B$2.2B15.9%

Institutions holding GEHC

Institutional investors reporting a position in GE HealthCare Technologies Inc. on SEC Form 13F.
InstitutionSharesValueReported
DODGE & COX37,864,164$2.4B2026-06-30
BlackRock37,467,843$2.4B2026-06-30
VANGUARD CAPITAL MANAGEMENT29,724,359$1.9B2026-06-30
STATE STREET20,861,566$1.3B2026-06-30
VANGUARD PORTFOLIO MANAGEMENT20,275,526$1.3B2026-06-30
Invesco Ltd.18,296,350$1.2B2026-06-30
HARRIS ASSOCIATES L P15,329,664$981.3M2026-06-30
BARROW HANLEY MEWHINNEY & STRAUSS13,455,814$861.3M2026-06-30
GEODE CAPITAL MANAGEMENT12,871,800$820.8M2026-06-30
HOTCHKIS & WILEY CAPITAL MANAGEMENT12,250,502$784.2M2026-06-30
GEHC

GE HealthCare Technologies Inc.

GEHC
NasdaqLarge CapHealthcare

13F Pro Quality Score

55.7/100

Rank #1,225 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

37.7/100

Profitability

55.6/100

Balance Sheet

71.4/100

Earnings Quality

52.4/100

Free Cash Flow

27.2/100

Institutional Flow

59.3/100

Revenue Scale

92.8/100

Dilution Risk

69.6/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q1 2026
EDGAR

$5.13B

Net Income

Q1 2026
EDGAR

$389.00M

EPS (Diluted)

Q1 2026
EDGAR

$0.85

Operating Margin

Q1 2026
EDGAR

10.0%

ROIC

Q1 2026
EDGAR

9.9%

Free Cash Flow

Q1 2026
EDGAR

$112.00M

Debt/Equity

Q1 2026
EDGAR

0.95

Top Institutional Holders

as of Q2 2026
$25.55B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…